Transvenous Extrahepatic Portosystemic Shunts (TEPS): Intravascular Ultrasound-Guided Creation of Portocaval, Mesocaval, and Splenorenal Shunts
Journal of Vascular and Interventional Radiology · 2026
DOI: 10.1016/j.jvir.2026.108596 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Vascular and Interventional Radiology, 2026. Verfasst von Aakash N Gupta und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Interventional Radiology, Stanford University, Stanford, California. Electronic address: https://twitter.com/aakashng17. Hauptthemen laut MEDLINE: Ultrasonography, Interventional, Gastrointestinal Hemorrhage, Hypertension, Portal, Esophageal and Gastric Varices. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: To evaluate the feasibility and long-term safety and effectiveness of intravascular ultrasound (IVUS)-guided transvenous extrahepatic portosystemic shunt (TEPS) creation for patients unsuitable for transjugular intrahepatic portosystemic shunt (TIPS) creation. MATERIALS AND METHODS: A single-center, retrospective study was performed in 23 patients (19 adult and 4 pediatric; median, 55.7 years; range, 8-75 years; 13 [57%] male) who underwent 24 TEPS creations for variceal bleeding (n = 20, 83%), refractory ascites (n = 3, 13%), or preoperative portal decompression (n = 1, 4%). Rationale for extrahepatic shunt included chronic portal vein occlusion (n = 17, 71%), chronic superior mesenteric vein occlusion (n = 2, 8%), obstructed intrahepatic path (n = 3, 13%), complex Budd-Chiari syndrome (n = 1, 4%), and intentional portosplenic blood flow separation (n = 1, 4%). Baseline characteristics included active cancer (n = 6, 27%), cirrhosis (n = 9, 41%), and liver transplant (n = 4, 22%). Primary outcomes were technical success and periprocedural adverse events. Secondary outcomes were patency, delayed adverse events, and overall survival (OS). RESULTS: Technical success was 100% for portocaval (n = 16, 67%), superior mesocaval (n = 5, 21%), inferior mesocaval (n = 1, 4%), and splenorenal (n = 2, 8%) shunts. Periprocedural adverse events included 9 Grade 1-2 events (38%) and 1 Grade 3 acute kidney injury (4%). One-year primary patency was 100%, and 3-year primary assisted patency was 100%. Recurrent variceal bleeding developed in 4 patients (17%); refractory ascites did not recur. Eight patients (36%) developed hepatic encephalopathy, managed medically. Hepatopulmonary and portopulmonary syndromes occurred in 1 patient each (4%; 4%). Median OS was 38.4 months, shorter in patients with active cancer (10.4 vs 104.8 months, P = .026). CONCLUSIONS: IVUS-guided TEPS creation is feasible, effective, and durable in patients with complications of portal hypertension not suitable for conventional recanalization or TIPS creation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Interventional Radiology, Stanford University, Stanford, California. Electronic address: https://twitter.com/aakashng17.
- Division of Interventional Radiology, Stanford University, Stanford, California.
- Division of Interventional Radiology, Stanford University, Stanford, California. Electronic address: dansze@stanford.edu.
Zitieren
APA
Gupta, A. N., Louie, J. D., & Sze, D. Y. (2026). Transvenous Extrahepatic Portosystemic Shunts (TEPS): Intravascular Ultrasound-Guided Creation of Portocaval, Mesocaval, and Splenorenal Shunts. Journal of Vascular and Interventional Radiology. https://doi.org/10.1016/j.jvir.2026.108596
Vancouver
Gupta AN, Louie JD, Sze DY. Transvenous Extrahepatic Portosystemic Shunts (TEPS): Intravascular Ultrasound-Guided Creation of Portocaval, Mesocaval, and Splenorenal Shunts. Journal of Vascular and Interventional Radiology. 2026. doi:10.1016/j.jvir.2026.108596
BibTeX
@article{Gupta2026,
author = {Gupta, Aakash N and Louie, John D and Sze, Daniel Y},
title = {Transvenous Extrahepatic Portosystemic Shunts (TEPS): Intravascular Ultrasound-Guided Creation of Portocaval, Mesocaval, and Splenorenal Shunts},
journal = {Journal of Vascular and Interventional Radiology},
year = {2026},
doi = {10.1016/j.jvir.2026.108596}
}
EUVIMED